[ASND] YoY Quarter Result on 31-Mar-2023 [#Q1]

Stock
[ASND] Ascendis Pharma A/S
Announcement Date
27-Apr-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- 46.53%
YoY- 11.62%
Quarter Report
ASND's Result
ASND's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Revenue 95,894 33,589 6,828 746 2,225 5,414 28 287.76%
PBT -128,527 -109,617 -125,257 -62,983 -63,394 -53,707 -41,482 20.72%
Tax 2,508 1,297 241 -191 -77 -70 -107 -
NP -131,035 -110,914 -125,498 -62,792 -63,317 -53,637 -41,375 21.16%
Tax Rate - - - - - - - -
Total Cost 226,929 144,503 132,326 63,538 65,542 59,051 41,403 32.74%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
NP Margin -136.65 -330.21 -1,837.99 -8,417.16 -2,845.71 -990.71 -147,767.86 -68.75%
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
EPS -2.30 -1.98 -2.21 -1.17 -1.32 -1.24 -1.07 13.59%
EPS Diluted -2.30 -1.98 -2.21 -1.17 -1.32 -1.24 -1.07 13.59%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.